Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

Glynne‐Jones, Rob; Sebag‐Montefiore, David; Meadows, Helen; Cunningham, David; Begum, Rubina; Adab, F.; Benstead, Kim; Harte, Robert; Stewart, Jill; Beare, Sandy; Hackshaw, Allan; Kadalayil, Latha

doi:10.1016/s1470-2045(17)30071-2

Public

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

Published in The Lancet Oncology • Feb 10, 2017

Authors:

Rob Glynne‐Jones

David Sebag‐Montefiore

Helen Meadows

Abstract

BACKGROUND: Guidelines for anal cancer recommend assessment of response at 6-12 weeks after starting treatment. Using data from the ACT II trial, we determined the optimum timepoint to assess clinical tumour response after chemoradiotherapy. METHODS: per day on days 1-4 and 29-32) and radiotherapy (...

Subject

Medicine

Chemoradiotherapy

Clinical trial

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!